Combining popular diabetes drugs offers complementary heart and kidney benefits, research finds
byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainNew research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor
Updated on: July 09,2024
0

Combining popular diabetes drugs offers complementary heart and kidney benefits, research finds
byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainNew research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor
Updated on:July 09,2024
0
